medical_managment-key.png

CANCER

GENETIC CANCER RISK

Endocrine

High Risk

Other

Elevated Risk

Renal

Elevated Risk

medical_managment-key.png

CANCER TYPE

PROCEDURE

CANCER RISK

RISK FOR GENERAL POPULATION *

Paraganglioma/Pheochromocytoma

To age 60

43% risk for tumors, only some of which will be malignant

<0.1%

Renal

To age 80

Elevated risk

1.4%

Gastrointestinal Stromal Tumors (GIST)

To age 80

Elevated risk

<0.1%

medical_managment-key.png

CANCER TYPE

PROCEDURE

AGE TO BEGIN

FREQUENCY

Paraganglioma/Pheochromocytoma

Clinical monitoring, including blood pressure measurement3, 4

6 to 8 years

Annually

Biochemical screening of serum and urine3, 4

6 to 8 years

Annually

Whole-body MRI with consideration of the head and neck3, 4

6 to 8 years

Every 2 years

Renal

Abdominal MRI (preferred) or CT, with and without IV contrast1

12 years

Every 4 to 6 years

Gastrointestinal Stromal Tumors (GIST)

Complete blood count and attention to symptoms such as gastric bleeding, obstruction, abdominal pain, nausea, etc.4

6 to 8 years

Annually